Forish v. Paul
Opinion of the Court
Presently before the court is a motion for summary judgment brought by defendant Eckerd Drugs Stores.
The essential facts are undisputed. During 1980, plaintiff Robert Forish was a patient of David B. Paul, M.D. a psychiatrist. Part of plaintiff’s treatment involved the use of prescription drugs including Norapramin, Librium, Dalmane, Trilafon and Mellaril. During the relevant time period plaintiff’s prescriptions were filled by defendant Eckerd Drug Stores. While under the care of Dr. Paul, plaintiff fell ill, suffering respiratory and cardiac arrest. After
Plaintiff’s wife filed a wrongful death and survival action alleging that plaintiffs psychiatrist was negligent in his treatment of decedent. Also included was a count against the pharmacy which had filled plaintiffs prescriptions, Eckerd Drugs. Plaintiffs allegations of negligence against defendant Eckerd Drugs consist of (a) failure to maintain a record of patient drug history; (b) failure to warn decedent of incompatibilities of the medications taken; (c) failure to consult with the decedent’s physician about the ongoing chemotherapy of decedent.
Defendant Eckerd Drugs has filed this motion for summary judgment based on two theories. First, defendant argues that as a matter of law Eckerd Drugs did not breach a duty of care owed to decedent. Alternatively, defendant argues that plaintiff has failed to show any causal connection between Eckerd’s alleged negligence and decedent’s death.
The court is now called upon to examine the parameters of a pharmacy’s duty in dealing with its customers. Specifically, the issue turns on the extent to which a pharmacist owes a duty in dispensing medications and in monitoring the patient’s use thereof. Defendant’s alternative argument involves a situation where a physician and a pharmacy owe the same or a similar duty. When the physician fulfills that duty, is the causal tie broken between the alleged negligent conduct of the pharmacist and the patient’s death, negating the pharmacist’s liability?
The standard required in ruling on a summary judgment motion is well settled. Summary judgment is properly granted in those cases where the evidence of record, taken as a whole, does not
Before any negligence cause of action can proceed to trial, it must be determined that the defendant owed a duty of care to the plaintiff. When injury is suffered by one not within the scope of a duty, such person has no right to recover because there has been no breach of duty with regard to him. This question is one of law, for the trial court in the first instance. Merritt v. City of Chester, 344 Pa. Super. 505, 496 A.2d 1220 (1985).
The parties do not dispute that a pharmacist owes no duty to its patient under either strict product liability as per the Restatement (Second) of Torts §402A, or under the Uniform Commercial Code for breach of implied warranty. Those issues were discussed at length by the Superior Court in Makripodos v. Merrell-Dow Pharmaceuticals Inc., 361 Pa. Super. 589, 523 A.2d 374 (1987). On the other hand, the appellate courts have recently attempted to clarify the degree of skill required of the pharmaceutical profession under a theory of common-law negligence. In order to better define the scope of a particular professional duty, it is necessary to first examine the regulations and statutory requirements governing same.
“The practice of phramacology is a regulated profession in Pennsylvania. Pharmacists are required to hold a degree in pharmacology from a school accredited by the American Council of Pharmaceutical Education, to complete an internship,
. . . ’Under 63 P.S. §390-6(h)(l), the State Board of. Pharmacy is empowered to regulate the practice of pharmacy.” Riff v. Morgan Pharmacy, 353 Pa. Super. 21, 28-9, 508 A.2d 1247, 1251 (1986). See generally 63 P.S. §390-1 et seq.
The court in the Riff case, supra, held that a pharmacy owes a legal duty to its patients to warn of obvious inadequacies appearing on the face of a prescription. A pharmacy is not a merely a warehouse for drugs. Based upon a careful reading of the common-law, statutory, and regulatory guidelines discussed above, it follows that a pharmacy’s duties fall into two broad categories. First, liability may flow from a pharmacist’s failure to remedy inadequacies on the face of a physician’s prescriptions. These might include failure to correct improper dosage directions; failure to check on illegible prescriptions; and failure to notice a potentially lethal interaction between drugs on the face of a prescription. Under these circumstances, the courts have determined that a pharmacist has a duty to alert the physician and make proper adjustments. See generally Riff v. Morgan Pharmacy. The second category involves negligence on the part of a pharmacist in the actual process of preparing and dispensing a medication pursuant to the orders of the physician. Into this area fall misreading a prescription; mislabeling; improper compounding; incorrect dosage (in strength or quantity); use of improper methods for dispensing; failure to ensure that a the drug is
Conversely, there exists no authority in Pennsylvania which would place on the pharmaceutical profession the following duties: to be familar with the patient’s medical history and/or medical records; to warn of all possible contraindications; to advise and consult with the patient’s treating physician (barring an inadequacy apparent on the face of the prescription); or to monitor the patient’s use of the presrciptions via patient profiles or records. In fact, imposition of such duties would force the pharmacist to interfere in the patient-physician relationship which our courts hold in high regard.
While it is interesting to note that some states do impose a duty, to maintain patient profiles upon the pharmaceutical profession, such a duty has no foundation in Pennsylvania law. To hold a pharmacist accountable for monitoring use makes little practical sense — a patient could have prescriptions filled at a number of different pharmacies, rendering any attempt at comprehensive record-keeping virtually impossible absent some type of state-wide regulatory scheme. Our legislature has not seen fit to require pharmacies to monitor patient use of medications. Pursuant to the rules of statutory construction, courts are precluded from imposing duties in addition to those which the legislative branch has chosen to set forth.
In summary, defendant Eckerd owed to plaintiff
Hence, plaintiffs allegations against defendant Eckerd Drug Stores have no basis in either fact or law, requiring a summary judgment ruling in defendant Eckerd’s favor.
Although the issue is rendered moot in view of the above holding, this court feels it is necessary to address defendant Eckerd’s alternative argument for summary judgment. To do so, it must be assumed, arguendo, that Eckerd owed to plaintiff a duty to warn and that the duty was breached.
The issue of causation is generally one of fact, within the province of a jury. A jury could conceive-ably find causation in the instant case. An illustrative example is the duty of professional responsibility and counsel'an attorney owes to a client. The fact that a client’s first attorney carries out the duties required of the profession would not relieve a subsequently-hired attorney from performing under the same standards. The fulfillment of a duty by one professional does not free from liability another professional who owes the same duty. As such, defendant in the case at bar would not be entitled to summary judgment based on the assumptions outlined above.
Given that there was no breach of duty on the part of Eckerd Drugs, this court enters summary judgment in favor of the defendant Eckerd Drug Stores, as against both the plaintiff and the defendant David M. Paul, M.D.
ORDER
And now, February 9, 1989, it is hereby ordered, adjudged and decreed that the motion for summary judment of defedant Eckerd Drug Stores is granted as against both plaintiff and the additional defendant David B. Paul, M.D. This court fully incorporates by reference the opinion attached hereto.
Case-law data current through December 31, 2025. Source: CourtListener bulk data.